<p>According to TechFlow, on November 20, Hoth Therapeutics, a publicly traded company in the United States, announced that its board of directors approved the purchase of up to 1 million USD in Bitcoin. Hoth's CEO Robb Knie stated, "As Bitcoin continues to grow and gradually becomes a major asset class, attracting attention and recognition from investors, we believe Bitcoin will serve as a strong financial reserve asset. With the recent approval of Bitcoin ETFs and increasing activity from institutional investors, Bitcoin will be a powerful complement to financial strategies. We believe Bitcoin's anti-inflation characteristics may make it a reliable asset with value storage capabilities."</p>

<div>
<p>According to a report by prnewswire on November 20, Deep Tide TechFlow announced that Hoth Therapeutics, a publicly listed company in the United States, has approved the purchase of up to 1 million USD in Bitcoin by its board of directors. Hoth's CEO Robb Knie stated: "With the ongoing growth of Bitcoin and its gradual recognition as a major asset class attracting the attention and acknowledgment of investors, we believe Bitcoin will become a powerful financial reserve asset. With the recent approval of Bitcoin ETFs and the increasing activity of institutional investors, Bitcoin will serve as a strong complement to financial strategies. We believe that Bitcoin's anti-inflation properties may make it a reliable asset with value storage capabilities."</p>
</div>

The board of Hoth Therapeutics, a publicly listed company in the United States, has approved the purchase of 1 million USD worth of BTC as a reserve asset.